Novel Lesional Transcriptional Signature Separates Atherosclerosis With and Without Diabetes in Yorkshire Swine and Humans.

Affiliation

Haemmig S(#)(1), Hashemi Gheinani A(#)(2)(3), Zaromytidou M(1), Siasos G(1), Coskun AU(1), Cormier MA(1), Gross DA(1), Wara AKMK(1), Antoniadis AP(1), Sun X(1), Sukhova GK(1), Welt FGP(4), Andreou I(1), Whatling C(5), Gan LM(5), Wikström J, Edelman ER(1)(6), Libby P(1), Stone PH(1), Feinberg MW(1).
Author information:
(1)Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital
(S.H., M.Z., G.S., A.U.C., M.A.C., D.A.G., A.K.W., A.P.A., X.S., G.K.S., I.A., E.R.E., P.L., P.H.S., M.W.F.), Harvard Medical School, Boston, MA.
(2)Department of Surgery, Urological Diseases Research Center, Boston Children Hospital
(A.H.G.), Harvard Medical School, Boston, MA.
(3)Broad Institute of MIT and Harvard, Cambridge, MA
(A.H.G.).
(4)Division of Cardiovascular Medicine, University of Utah Health Sciences Center, Salt Lake City
(F.G.P.W.).
(5)Bioscience Cardiovascular/Early Clinical Development/Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
(C.W., L.-M.G., J.W.).
(6)Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge
(E.R.E.).
(#)Contributed equally

Abstract

[Figure: see text].